<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5664">
  <stage>Registered</stage>
  <submitdate>19/09/2013</submitdate>
  <approvaldate>19/09/2013</approvaldate>
  <nctid>NCT01980511</nctid>
  <trial_identification>
    <studytitle>Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN</studytitle>
    <scientifictitle>Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN</scientifictitle>
    <utrn />
    <trialacronym>NeuroVISION</trialacronym>
    <secondaryid>NeuroVISION v3.0</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Covert Postoperative Stroke</healthcondition>
  </conditions>
  <interventions>
    <interventions />
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Postoperative cognitive dysfunction - Cognitive dysfunction, as measured by a decrease of on the Montreal Cognitive Assessment (MoCA) scale.</outcome>
      <timepoint>1 year</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Measuring the incidence of acute postoperative covert stroke - We will detect postoperative covert strokes using a MRI study of the brain that will be performed between postoperative days 3 and 9.</outcome>
      <timepoint>30 days</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measuring postoperative delirium - Delirium will be measured using the Cognitive Assessment Method (CAM).</outcome>
      <timepoint>30 days</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measuring physical function after surgery - Physical function will be measured using two instruments; the Modified Rankin Scale and the Lawton Instrumental Activities of Daily Living (iADL) Scale.</outcome>
      <timepoint>30 days and 1 year</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measuring quality of life after surgery - We will use the EQ-5D questionnaire to assess the patients' health-related quality of life.</outcome>
      <timepoint>30 days and 1 year</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measuring depressive symptoms after surgery - We will use the 5-question version of the Geriatric Depression Scale (GDS-5) to depressive symptoms.</outcome>
      <timepoint>30 days and 1 year</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measuring clinical outcomes - Clinical outcomes: acute cerebral ischemia, covert stroke, overt stroke, transient ischemic attack, delirium, death, myocardial infarction (MI), myocardial injury after noncardiac surgery (MINS), nonfatal cardiac arrest, major adverse cardiovascular events (composite), cardiac revascularization procedures, bleeding, new atrial fibrillation, hypotension, congestive heart failure, new acute renal failure, infection, and dementia and mild cognitive impairment.</outcome>
      <timepoint>30 days and 1 year</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Age =65 years old

          -  An anticipated hospital stay of at least 2 days after elective noncardiac surgery that
             occurs under general or neuraxial anesthesia

          -  Written informed consent for potential participation prior to noncardiac surgery</inclusivecriteria>
    <inclusiveminage>65</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Contraindication to MRI (e.g. implanted devices not safe for MRI studies,
             claustrophobia, unable to lie flat or still),

          -  Unable or unwilling to attend the follow-up appointments,

          -  Documented history of dementia

          -  Residing in a nursing home,

          -  Undergoing carotid artery surgery or intracranial surgery

          -  Unable to complete neurocognitive testing due to language, vision or hearing
             impairment,

          -  Unable to communicate with the research staff due to language barriers,

          -  Previously enrolled in the NeuroVISION Study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>1121</actualsamplesize>
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/09/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Wisconsin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>British Columbia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Chile</country>
      <state>Santiago</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hong Kong</country>
      <state>SAR</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Bangalore</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state>Kuala Lumpur</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Peru</country>
      <state>Lima</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Krakow</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Hamilton Health Sciences Corporation</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>McMaster University</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Health and Medical Research Fund, Food and Health Bureau, Hong Kong</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Prince of Wales Hospital, Shatin, Hong Kong</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Chinese University of Hong Kong</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The NeuroVISION Study will characterize the incidence, impact, and risk factors of covert
      stroke in adults undergoing noncardiac surgery. We will determine the incidence of acute
      covert stroke using an MRI study of the brain in the days following noncardiac surgery. We
      will characterize the epidemiology and the impact of covert stroke in patients undergoing
      noncardiac surgery, and its association with cerebral deoxygenation.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01980511</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>P.J. Devereaux, MD, PhD</name>
      <address>Population Health Research Institute</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>